What is Hydroxychloroquine?
Category: Prescription Drugs
Most popular types: Plaquenil Hydroxychlor Apo-hydroxyquine Show all
Hydroxychloroquine is an antimalarial, used for the treatment of malaria. It may also be used to manage discoid or systemic lupus erythematosus and rheumatoid arthritis.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Systemic lupus erythematosus | 22709 | 766 | |
| Rheumatoid arthritis | 3644 | 385 | |
| Mixed connective tissue disease | 634 | 84 | |
| Undifferentiated connective tissue disease | 446 | 59 | |
| Subacute cutaneous lupus erythematosus | 178 | 15 | |
| Sjogren's syndrome | 125 | 61 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 168 | |
| Moderate | 219 | |
| Mild | 294 | |
| None | 687 |
Commonly reported side effects and conditions associated with Hydroxychloroquine
| Side effect | Patients | Percentage |
|---|---|---|
| Nausea | 116 | |
| Diarrhea | 59 | |
| Blurry vision | 45 | |
| Headaches | 35 | |
| Stomach pain | 30 | |
| Hair loss | 22 |
Why patients stopped taking Hydroxychloroquine
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Side effects too severe | 312 | |
| Did not seem to work | 274 | |
| Doctor's advice | 240 | |
| Other | 112 | |
| Course of treatment ended | 34 | |
| Personal research | 21 | |
| Change in health plan coverage | 17 | |
| Expense | 17 |
Duration
Stopped taking Hydroxychloroquine
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 123 | |
| 1 - 6 months | 155 | |
| 6 months - 1 year | 108 | |
| 1 - 2 years | 92 | |
| 2 - 5 years | 112 | |
| 5 - 10 years | 67 | |
| 10 years or more | 54 |
What people switch to and from
Patients started taking Hydroxychloroquine after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Prednisone (Prednisone Intensol) | 57 | |
| Methotrexate (Apo-Methotrexate) | 40 | |
| Azathioprine (Imuran) | 10 | |
| Mycophenolate mofetil (CellCept) | 8 | |
| Sulfasalazine (Salazopyrin) | 8 |
Patients stopped taking Hydroxychloroquine and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Methotrexate (Apo-Methotrexate) | 84 | |
| Prednisone (Prednisone Intensol) | 26 | |
| Leflunomide (Arava) | 22 | |
| Azathioprine (Imuran) | 17 | |
| Mycophenolate mofetil (CellCept) | 14 |
Last updated: